In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...

The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent ...

The pharmaceutical company said Thursday that the U.S. Advisory Committee on Immunization Practices had issued a positive recommendation on GSK's 5-in-1 meningitis vaccine Penmenvy as well as its ...

The Onychomycosis Treatment Market in Europe has witnessed substantial growth in recent years, with a valuation of Onychomycosis Treatment Market. Projections suggest a steady upward trajectory, ...

In a Phase 3 randomized trial of more than 600 people, an antibiotic pill called gepotidacin (normally used to treat UTIs) ...

This innovative oral antibacterial treatment poses a promising defense against the increasingly drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for the infection.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

In the INSPIRE 3 Skin and Soft Tissue randomized clinical trial, the real-time computerized provider order entry (CPOE) ...

In this week’s edition of InnovationRx, we look at the impact of tariffs on healthcare costs, pioneers of treating MS, AI for ...

A petition is urging the government to update the Personal Independence Payment (PIP) application form to include a key figure: the success rate of appealing a PIP decision. The PIP application ...

Cook County’s pilot program to provide guaranteed income to more than 3,000 people did what it was intended to do, early findings suggest — it helped provide some economic stability.